Effects of <i>Curculigo orchioides</i> total glucosides in mouse perimenopause model of related organization and organs morphology
The purpose of this study was to examine the effects of Curculigo orchioides total glucosides in mouse perimenopause model. The castrated mice were treated with different doses of soybean isoflavone soft capsule, Gengnianan, C. rhizome total glycoside. Hypothalamus, thymus, spleen and uterus were collected and then fixed in 10% formaldehyde, HE staining, to observe the pathological changes of morphology. The results indicate that compared with the model group, soybean isoflavone soft capsule, gengnianan capsule and big, medium, small dose of C. rhizome total glycoside group could significantly improved the pathological changes in mouse uterus, hypothalamic, thickening of the thymic cortex and significantly increased the number of lymphocytes in the cortex, increased the volume of splenic nodule (p<0.01), in which the effect of large dose of C. orchioides total glycosides group was the best. In conclusion, C. orchioides total glucosides in mice caused by perimenopausal pathological changes of uterine, hypothalamus, spleen and other organs have good improvement effect.
Ashwini AM, Puttarudrappa L, Ravi BV, Majumdar M. GC-MS analysis, evaluation of phytochemicals, anti-oxidant, thrombolytic and anti-inflammatory activities of Exacum bicolor. Bangladesh J Pharmacol. 2015; 10: 745-52.
Cao S. The analysis of Shensongyangxin capsule in the treatment of female climacteric syndrome and arrhythmia efficacy. Chinese Mod Med J. 2009; 11: 98-99.
Ge S, Peng W, Li D, Mo B, Zhang M, Qin D. Study on antibacterial molecular drugs in Eucalyptus granlla wood extractives by GC-MS. Pakistan J Pharmacol Sci. 2015; 28S: 1445-48.
Huo S, Kong A. The effect of the decoction of tonifying the kidney and strengthening the spleen for perimenopausal syndrome patients with hormone and IL-2. Inner Mongolia J Tradit Chinese Med. 2014; 47-48.
Huo X, Zhang X, Ma C. The water extract of Curculigo orchioides rats after composition into the blood of. Chinese J TCM. 2012; 27: 2290-93.
Li D, Meng L, Zhang K, Zhang W. Anti-cancer and apoptotic effects of theaflavin-3-gallate in non-small cell lung carcinoma. Bangladesh J Pharmacol. 2015; 10: 790-98.
Li D, Peng W, Ge S, Mo B, Zhang Z, Qin D. Analysis on active molecules in Populus nigra wood extractives by GC-MS. Pakistan J Pharmacol Sci. 2014; 27S: 2061-65.
Li R, Bai M, Miao M. Syndrome characteristics and the prospect of the menopause syndrome animal model. Chinese J Med. 2012; 27: 708-10.
Li Y, Wang Q. The experimental methods of Traditional Chinese Medicine pharmacology. Shanghai, Shanghai Sci and Technol Press, 1991.
Ling B, Fu P, Ma X. Fu Ping experience in the treatment of menopause syndrome. J Zhejiang Chinese Med University 2015; 39: 32-34.
Liu S, Cao S, Miao M. Analysis of pharmacological effect of traditional Chinese medicine for the treatment of benign prostatic hyperplasia. Chinese J Med. 2011; 26: 1326-29.
Liu S, Miao M. Based on the new theory of Traditional Chinese Medicine with Traditional Chinese Medicine for the innovation and development. Chinese J TCM. 2012; 27: 1309-13.
Man Y, Zhao L, Chen Y. Research on the pathogenesis of Chinese and Western medicine in perimenopausal syndrome. Chinese TCM Mod Dist Edu. 2011; 9: 138-39.
Nie Z, Chen Y. Discussion on the etiology and pathogenesis of peri menopausal syndrome from the angle of deficiency of the kidney. Guangming TCM. 2015; 30: 258-60.
Pan H, Su T, Luo Q. The progress of electro acupuncture for treatment of perimenopausal syndrome of traditional Chinese medicine research. Shanxi Tcm. 2015; 36: 383-84.
Qi Q. The research progress of traditional Chinese medicine in the treatment of perimenopausal syndrome. Hunan J Tcm. 2014; 30: 189-91.
Su E. Mechanism of erxian decoction in treatment of osteoporosis in postmenopausal women. Liaoning J University TCM. 2012; 17: 172-74.
Su L, Mao Y, Li Y. Reconcile the five internal organs for treatment of perimenopausal syndrome. Liaoning J Tradit Chinese Med. 2014; 41: 2584-85.
Sun J, Zhou F. The outline of The Chinese medicine treatment of menopausal syndrome. Tradit Chinese Med. 2010; 28: 860-63.
Sun Y, Jin R. The study preparation of female climacteric syndrome animal model. Lishizhen Med and Chinese Med. 2015; 16: 657-59.
Vijayanarayana K, Rodrigues RS, Chandrashekhar KS, Subrahmanyama ES. Evaluation of estrogenic activity of alcoholic extract of rhizomes of Curculigo orchioides. J Ethnopharmacol. 2007; 114: 241-45.
Wang B, Liu H, Wang H. Experimental study of Gengnianle on climacteric syndrome of network mechanism. Jiangsu J Tradit Chinese Med. 2002; 23: 56.
Wang Y, Feng J, Wang W. The development of treating perimenopausal syndrome. Hebei Med J. 2010; 32: 2.
Weng X. The analysis of perimenopausal women's health status and related influencing factors. Chinese Maternal Child Health Care. 2013; 28: 1304-05.
Wong F, Zheng Y, Xiao H. The timing of taking Epimedium effects on hormone levels. J Tradit Chinese Med. 2001; 42: 619-20.
Xia B, Meng Q, Lin J. Effects of Er-xian decoction and daidzein have on ovarian morpholoy and function of menopqusal syndrome model rats. Guiding J Tradit Chinese Med Pharm. 2015; 21: 28-32.
Yang G, Ye F. The overview of pharmacological action and clinical application of Curculigo orchioides. Chinese Pharm. 2011; 14: 1039-41.
Yin J, Zhao C, Guan S. Effect of invigorating the kidney and regulating the spleen of female climacteric syndrome of glucose and lipid metabolism. Chinese Clin Lab Sci J. 2013; 19: 282-86.
Yu S, Liu H, Miao M. Climacteric syndrome and its molecular mechanism and traditional Chinese medicine treatment of the climacteric syndrome characteristics. Chinese J Med. 2012; 27: 338-39.
Zhu Y, Xu H, Zhou W. The correlation between the perimenopausal women estrogen levels and cardiovascular disease. Chinese Maternal Child Health Care. 2015; 30: 248-49.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).